SESSION TITLE: Pulmonary Vascular Disease II
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM
PURPOSE: Parenteral prostacyclin therapy is integral to treating advanced pulmonary arterial hypertension (PAH). However, some patients may benefit from earlier palliative care involvement and consideration for hospice. We aimed to identify factors that influence providers’ decision making for patients with advanced PAH.